0001698998-20-000006.txt : 20200310
0001698998-20-000006.hdr.sgml : 20200310
20200310153419
ACCESSION NUMBER: 0001698998-20-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200306
FILED AS OF DATE: 20200310
DATE AS OF CHANGE: 20200310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woolson Daniel
CENTRAL INDEX KEY: 0001698998
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 20701350
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC., 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-03-06
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001698998
Woolson Daniel
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
VP, GM-Infusion Capital
Common Stock
2020-03-06
4
M
0
1443
0.0
A
6643
D
Common Stock
2020-03-06
4
F
0
639
0.0
D
6004
D
Common Stock
2020-03-06
4
M
0
1443
0.0
D
2022-03-06
Common Stock
1443
2888
D
These Securities are Performance-based Restricted Stock Units (PRSU).
There is neither a purchase price nor an exercise price for the PRSUs.
Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 100% of the target award amount.
These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
2020-03-10